The function of the urea cycle is to remove excess nitrogen from the body. Six distinct enzymes comprise the urea cycle, and urea cycle disorders (UCD) are a direct results of deficiency in any one of those enzymes. N-acetylglutamate synthase (NAGS) catalyzes the conversion of N-acetylglutamate (NAG) from glutamate and acetylcoenzyme A. NAG is an obligatory activator of carbamylphosphate I (CPSI), the first and rate limiting enzyme of ureagenesis. Therefore, deficiency of NAGS results in severe hyperammonemia. Twenty one mutations have been described in humans, ten of which are associated with acute neonatal hyperammonemia, and the remainder found in patients with late onset disease. Treatment with N-carbamylglutamate (NCG) can ameliorate hyperammonemia for inherited and secondary NAGS deficiency. Expression of NAGS occurs in the liver, small intestine and kidney.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPELISA
recommended for detection of NAGS of mouse, rat, human and canine origin by WB, IP and ELISA: